KRONOX vs SHK: Stock Comparison

Kronox Lab Sciences Limited vs S H Kelkar and Company Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

S H Kelkar and Company Limited is the larger company by market capitalisation. Kronox Lab Sciences Limited shows a lower P/E, a higher ROE and lower leverage, while S H Kelkar and Company Limited shows a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Kronox Lab Sciences Limited and S H Kelkar and Company Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KRONOX is more favourable on 9 of 13 scored metrics and SHK on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SHK is the larger company
₹1,932 Cr vs ₹569 Cr
P/E Ratio
KRONOX has a lower P/E
20.7x vs 28.31x
P/B Ratio
SHK has a lower P/B
1.44x vs 4.93x
EPS
KRONOX has higher earnings per share
₹7.45 vs ₹5.01
Dividend Yield
SHK has a higher dividend yield
1.54% vs 0.33%
Revenue Growth (TTM YoY)
SHK has faster revenue growth
13.8% vs 0%
EPS Growth (TTM YoY)
KRONOX has faster EPS growth
26.7% vs -98.2%
Qtr Sales Growth
SHK has stronger quarterly sales growth
14.6% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKRONOXSHK
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricKRONOXSHK
Live Price₹154.39₹140.65
Day Change1.3%0.05%
Volume86,6612.17 L
52-Week High₹187.91₹275.5
52-Week Low₹96₹111.98
Distance from 52W High-17.84%-48.95%

Valuation

MetricKRONOXSHK
Market Cap₹569 Cr₹1,932 Cr
P/E Ratio20.7x28.31x
P/B Ratio4.93x1.44x
EPS₹7.45₹5.01
Book Value₹31.64₹95.7
Dividend Yield0.33%1.54%

Growth

MetricKRONOXSHK
Revenue Growth (TTM YoY)0%13.8%
EPS Growth (TTM YoY)26.7%-98.2%
Qtr Sales Growth0%14.6%
Qtr Profit Growth26.6%-96.2%

Profitability & Leverage

MetricKRONOXSHK
ROE26.8%3.71%
ROCE36%5.85%
Net Margin27.21%2.94%
Operating Margin33.9%10.2%
Debt to Equity0.01x0.76x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKRONOXSHK
Promoter Holding74.21%43.4%
FII Holding0.04% 0.04 pp5.92% 1.5 pp
DII Holding2.07% 0.02 pp6.01% 0.83 pp
Public Holding23.67% 0.01 pp33.21% 0.68 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Kronox Lab Sciences Limited and S H Kelkar and Company Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.